Ascertain Systems, Inc. — SEC Form D Filing

Ascertain Systems, Inc. filed an SEC Form D on October 19, 2026, reporting $20.00M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
October 19, 2026
Amount reported
$20.00M
Round stage
Series A
Industry
Healthcare Technology
Website
https://www.ascertain.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Healthcare teams are weighed down by high-cost, repetitive administrative paperwork and manual workflows, such as prior authorizations, referrals, and eligibility checks, that slow down operations and take time away from patient care.

Solution

Ascertain provides an automation platform with human-in-the-loop review that connects with existing healthcare systems to ingest unstructured data, automate forms, and manage workflows across revenue cycle and care management.

Why now

Rising clinician burnout, escalating healthcare administrative costs, and recent breakthroughs in multimodal and agentic AI allow complex, document-heavy healthcare workflows to be automated reliably.

Verdict

This cleared because investors urgently bought the labor-replacement thesis in back-office healthcare operations, not because the underlying agentic architecture was uniquely defensible. Allocators wagered $20M that Ascertain could package multimodal ingestion and human-in-the-loop validation into health systems before legacy RPA providers or Epic could harden their own automation suites. Long-term upside remains capped by diffuse enterprise buyer targeting across both clinical and revenue cycle operations, exposing the platform to commoditization once foundation models handle messy healthcare document extraction natively.

Source: SEC EDGAR Form D filing